Festival of Biologics 2024
Discover our comprehensive CDMO capabilities for large molecules
October 15-17, 2024 | Basel, Switzerland | Booth #142
About the Festival of Biologics 2024
The Festival of Biologics 2024 will gather senior professionals from across the biologics value chain to advance the industry and improve patient health. From discovery and development to manufacturing and market access, this event covers every stage of biologics.
Over three days, hear from industry leaders, global regulators, and top academics as they share cutting-edge insights and the latest advancements. Join us at booth #142 to meet our experts and see how our integrated CDMO solutions can support your biologics needs.
Event details
Date: October 15-17, 2024
Format: In-person
Location: Hall 1, Messe Basel
Booth number: #142
Event website: https://www.terrapinn.com/conference/festival-of-biologics/index.stm
Why Thermo Fisher Scientific?
Thermo Fisher Scientific is an industry-leading CDMO with services and solutions for biologics, offering end-to-end support for every stage of biologic drug development—from initial research to clinical trials and market commercialization.
Our expertise is built on a foundation of innovation and excellence, evident in every step of our workflow. We blend strategic foresight with operational mastery to deliver exceptional results, making us a trusted partner in the biologics field.
With unmatched insight and expertise, our integrated biologics solutions bring simplicity, speed, and scalability to every project, ensuring a seamless transition from molecule to medicine. Find your missing element with Thermo Fisher Scientific.
Attend our session
The critical role of the 5,000L bioreactor: Bridging drug substance supply needs between early and late-stage development
Date: Tuesday, October 15, 2024
Time: 11:55 a.m. CEST
Successfully transitioning biologic products from early-stage supply to late-stage supply and commercialization is a complex process.
This presentation will examine how critical decisions influence scalability and market readiness, with a focus on leveraging 5,000L bioreactors.
Key insights:
- Development needs for scaling up biologics to meet late-stage demands
- Use cases and design attributes of the new bioreactor system family
- How 5,000L bioreactors enhance production efficiency and reduce costs
Meet our speakers:
Erica Byerley
Senior Tech Transfer Engineer
Thermo Fisher Scientific
Julia Braunmüller
Manager, Scientific and Technical Affairs
Thermo Fisher Scientific
Let’s connect at the Festival of Biologics 2024
Schedule a meeting with Thermo Fisher Scientific at the Festival of Biologics 2024 to discover our industry-leading biologics drug development and manufacturing services and solutions for large molecules like yours.
We look forward to seeing you in Basel.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon